CN102283800B - 一种治疗阴道炎的硝酸舍他康唑栓剂及其制备方法 - Google Patents
一种治疗阴道炎的硝酸舍他康唑栓剂及其制备方法 Download PDFInfo
- Publication number
- CN102283800B CN102283800B CN2011101785316A CN201110178531A CN102283800B CN 102283800 B CN102283800 B CN 102283800B CN 2011101785316 A CN2011101785316 A CN 2011101785316A CN 201110178531 A CN201110178531 A CN 201110178531A CN 102283800 B CN102283800 B CN 102283800B
- Authority
- CN
- China
- Prior art keywords
- sertaconazole
- suppositorium
- colpitic
- suppository
- nitrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HAAITRDZHUANGT-UHFFFAOYSA-N 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1C(OCC=1C2=CC=CC(Cl)=C2SC=1)CN1C=NC=C1 HAAITRDZHUANGT-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 229960004476 sertaconazole nitrate Drugs 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000000829 suppository Substances 0.000 title abstract description 47
- 206010046914 Vaginal infection Diseases 0.000 title abstract description 13
- 201000008100 Vaginitis Diseases 0.000 title abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 10
- 239000003381 stabilizer Substances 0.000 claims abstract description 7
- JLGKQTAYUIMGRK-UHFFFAOYSA-N 1-{2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=1C2=CC=CC(Cl)=C2SC=1)CN1C=NC=C1 JLGKQTAYUIMGRK-UHFFFAOYSA-N 0.000 claims description 26
- 229960005429 sertaconazole Drugs 0.000 claims description 26
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 24
- 239000000758 substrate Substances 0.000 claims description 17
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 15
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 12
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 12
- JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims description 8
- 239000000872 buffer Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 239000006216 vaginal suppository Substances 0.000 claims description 5
- 229940120293 vaginal suppository Drugs 0.000 claims description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 238000013138 pruning Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 239000002511 suppository base Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims 9
- 230000000694 effects Effects 0.000 abstract description 12
- 210000001215 vagina Anatomy 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 6
- 239000011159 matrix material Substances 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 238000002844 melting Methods 0.000 abstract description 2
- 230000008018 melting Effects 0.000 abstract description 2
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 239000006172 buffering agent Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- MCCACAIVAXEFAL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 MCCACAIVAXEFAL-UHFFFAOYSA-N 0.000 description 8
- 229960005040 miconazole nitrate Drugs 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 229960004022 clotrimazole Drugs 0.000 description 5
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 5
- -1 fatty acid ester Chemical class 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 206010047786 Vulvovaginal discomfort Diseases 0.000 description 3
- 210000003756 cervix mucus Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- ZCJYUTQZBAIHBS-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)benzyl]oxy}ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=1C=CC(SC=2C=CC=CC=2)=CC=1)CN1C=NC=C1 ZCJYUTQZBAIHBS-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 229960001274 fenticonazole Drugs 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 229960000282 metronidazole Drugs 0.000 description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229910052567 struvite Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
实施例 | 释放度1 | 释放度2 | 释放度3 | 释放度4 | 释放度5 | 释放度6 |
1 | 55% | 58% | 65% | 64% | 61% | 58% |
2 | 61% | 58% | 51% | 64% | 61% | 65% |
3 | 58% | 53% | 62% | 57% | 54% | 58% |
实施例 | 释放度1 | 释放度2 | 释放度3 | 释放度4 | 释放度5 | 释放度6 |
4 | 60% | 52% | 58% | 61% | 55% | 57% |
5 | 59% | 53% | 55% | 55% | 53% | 64% |
6 | 58% | 55% | 56% | 58% | 57% | 53% |
7 | 67% | 68% | 62% | 61% | 65% | 64% |
8 | 61% | 69% | 61% | 67% | 61% | 56% |
9 | 55% | 52% | 57% | 62% | 59% | 49% |
10 | 63% | 65% | 60% | 61% | 60% | 59% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101785316A CN102283800B (zh) | 2011-06-29 | 2011-06-29 | 一种治疗阴道炎的硝酸舍他康唑栓剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101785316A CN102283800B (zh) | 2011-06-29 | 2011-06-29 | 一种治疗阴道炎的硝酸舍他康唑栓剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102283800A CN102283800A (zh) | 2011-12-21 |
CN102283800B true CN102283800B (zh) | 2012-11-21 |
Family
ID=45330741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101785316A Active CN102283800B (zh) | 2011-06-29 | 2011-06-29 | 一种治疗阴道炎的硝酸舍他康唑栓剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102283800B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109453106A (zh) * | 2019-01-09 | 2019-03-12 | 山东大学 | 一种海藻糖栓剂及其制备方法和应用 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103893107B (zh) * | 2014-04-10 | 2016-02-24 | 哈尔滨欧替药业有限公司 | 硝酸舍他康唑阴道膨胀栓及其制备方法和检测方法 |
CN112494443A (zh) * | 2020-12-12 | 2021-03-16 | 海南海神同洲制药有限公司 | 精准缓释片及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152167A (zh) * | 2007-09-06 | 2008-04-02 | 武汉大学 | 一种治疗慢性宫颈炎的异甘草素阴道栓剂及制备方法 |
CN101375835A (zh) * | 2008-09-19 | 2009-03-04 | 海南海神同洲制药有限公司 | 外用硝酸舍他康唑栓剂 |
CN101698101A (zh) * | 2008-12-02 | 2010-04-28 | 济南宏瑞创博医药科技开发有限公司 | 一种治疗阴道炎的药物组合物 |
CN101744833A (zh) * | 2008-12-02 | 2010-06-23 | 济南宏瑞创博医药科技开发有限公司 | 一种治疗细菌性阴道炎的药物组合物 |
-
2011
- 2011-06-29 CN CN2011101785316A patent/CN102283800B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152167A (zh) * | 2007-09-06 | 2008-04-02 | 武汉大学 | 一种治疗慢性宫颈炎的异甘草素阴道栓剂及制备方法 |
CN101375835A (zh) * | 2008-09-19 | 2009-03-04 | 海南海神同洲制药有限公司 | 外用硝酸舍他康唑栓剂 |
CN101698101A (zh) * | 2008-12-02 | 2010-04-28 | 济南宏瑞创博医药科技开发有限公司 | 一种治疗阴道炎的药物组合物 |
CN101744833A (zh) * | 2008-12-02 | 2010-06-23 | 济南宏瑞创博医药科技开发有限公司 | 一种治疗细菌性阴道炎的药物组合物 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109453106A (zh) * | 2019-01-09 | 2019-03-12 | 山东大学 | 一种海藻糖栓剂及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102283800A (zh) | 2011-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101919807B (zh) | 栓剂组合物 | |
CN101744833B (zh) | 一种治疗细菌性阴道炎的药物组合物 | |
CN103041311B (zh) | 含有膨胀载体的保妇康栓 | |
KR20100016060A (ko) | 부인과 질환의 치료에서의 락트산 올리고머의 용도 | |
CN102283800B (zh) | 一种治疗阴道炎的硝酸舍他康唑栓剂及其制备方法 | |
CN101147735A (zh) | 注射用药物组合物及其药盒 | |
CN102144988A (zh) | 一种壳聚糖宫颈抗菌膜及其制备方法 | |
CN102000339A (zh) | 缓释释药的药物载体 | |
CN102000341B (zh) | 在栓剂组合物中的聚氧化乙烯及基质型表面活性剂 | |
KR20200027519A (ko) | 신규한 세크니다졸 연질 젤라틴 캡슐 제형 및 그의 용도 | |
CN102302505B (zh) | 治疗盆腔炎的药物组合物及其应用 | |
CN100394919C (zh) | 一种用于治疗阴道疾病的药物组合物 | |
CN101455715B (zh) | 一种用于治疗妇科疾病的栓剂及其制备方法 | |
CN106902074A (zh) | 一种兽用利福昔明双层凝胶栓剂及其制备方法 | |
CN102058709A (zh) | 一种具有抗解脲支原体和人型支原体感染作用的花椒提取物 | |
CN105434456B (zh) | 一种几丁糖丹参注射液及其制备方法 | |
CN100592912C (zh) | 一种治疗妇科疾病的外用复方制剂及其制备方法 | |
CN1911246A (zh) | 一种治疗妇科炎症的蒙药及其制造工艺 | |
CN100340263C (zh) | 一种用于治疗细菌性阴道炎的栓剂及其制备方法 | |
RU2486911C1 (ru) | Средство для спринцевания влагалища в фазу влагалищной микрофлоры после лечения бактериального вагиноза и кандидозного кольпита (молочницы) | |
CN111588691B (zh) | 一种用于治疗阴道炎的伊曲康唑原位液晶凝胶制剂及其制备方法 | |
AU2021104085A4 (en) | Hpv-resistant lactic acid bacteria gynecological preparation and application thereof | |
CN115590908B (zh) | 一种中药组合物、抗抑菌喷剂及制备方法 | |
CN109248140A (zh) | 黄体酮抗菌阴道环的制备方法和应用 | |
CN101069680B (zh) | 2-羟基-4-甲基苯磺酸在制备药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Two road 570311 in Hainan province Haikou city national high tech Zone Industrial Park No. 6 trough trough Hainan Haisheng TongZhou Pharmaceutical Co. Ltd. Applicant after: HAINAN HISHEN TONGZHOU PHARMACEUTICAL Co.,Ltd. Address before: 570216 southwest corner, building eight, Haikou Free Trade Zone, Hainan Applicant before: HAINAN HISHEN TONGZHOU PHARMACEUTICAL Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20111221 Assignee: HAINAN HISHEN QIMAI PHARMACEUTICAL DEVELOPMENT CO.,LTD. Assignor: HAINAN HISHEN TONGZHOU PHARMACEUTICAL Co.,Ltd. Contract record no.: 2013460000019 Denomination of invention: Sertaconazole nitrate suppository for treating vaginitis and preparation method thereof Granted publication date: 20121121 License type: Exclusive License Record date: 20130830 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Nitrate Sertaconazole Suppository for the Treatment of Vaginitis and Its Preparation Method Granted publication date: 20121121 Pledgee: Industrial Bank Co.,Ltd. Haikou Branch Pledgor: HAINAN HISHEN TONGZHOU PHARMACEUTICAL Co.,Ltd. Registration number: Y2024980020578 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |